These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6350023

  • 21. Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP, Hanssen M.
    Drugs; 1987; 33 Suppl 3():282-5. PubMed ID: 3315608
    [Abstract] [Full Text] [Related]

  • 22. [Thrombolytics and their use].
    Alessi MC, Juhan-Vague I.
    Rev Prat; 1999 Oct 01; 49(15):1654-8. PubMed ID: 10581996
    [Abstract] [Full Text] [Related]

  • 23. [Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction].
    Bassand JP, Cassagnes J, Machecourt J, Anguenot T, Lusson JR, Borel E, Schiele F, Wolf JF, Vachet D.
    Arch Mal Coeur Vaiss; 1990 Feb 01; 83 Spec No 1():31-6. PubMed ID: 2108644
    [Abstract] [Full Text] [Related]

  • 24. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Rothbard RL.
    Drugs; 1987 Feb 01; 33 Suppl 3():276-8. PubMed ID: 3315606
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the hypotensive effects of streptokinase-(human) plasmin activator complex and BRL 26921 (p-anisoylated streptokinase-plasminogen activator complex) in the dog after high dose, bolus administration.
    Green J, Dupe RJ, Smith RA, Harris GS, English PD.
    Thromb Res; 1984 Oct 01; 36(1):29-36. PubMed ID: 6390776
    [Abstract] [Full Text] [Related]

  • 26. Randomised multicentre trial of anisoylated plasminogen streptokinase activator complex versus heparin. Interim results.
    Meinertz T, Kasper W.
    Drugs; 1987 Oct 01; 33 Suppl 3():223-6. PubMed ID: 3315597
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Efficacy data.
    Chamberlain DA.
    Drugs; 1987 Oct 01; 33 Suppl 3():221-2. PubMed ID: 3315596
    [No Abstract] [Full Text] [Related]

  • 28. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Rothbard RL, Anderson JL, Fitzpatrick PG, Hakworthy RA, Sorensen SG, Marder VJ.
    Clin Cardiol; 1990 Mar 01; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
    [Abstract] [Full Text] [Related]

  • 29. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C.
    Klin Wochenschr; 1988 Mar 01; 66 Suppl 12():50-4. PubMed ID: 2964542
    [Abstract] [Full Text] [Related]

  • 30. Evidence for the progressive uptake of anisoylated plasminogen streptokinase activator complex by clots in human plasma in vitro.
    Fears R, Ferres H, Standring R.
    Drugs; 1987 Mar 01; 33 Suppl 3():51-6. PubMed ID: 2960513
    [No Abstract] [Full Text] [Related]

  • 31. [New thrombolytic agents].
    Nguyen G, Samama M.
    Ann Biol Clin (Paris); 1987 Mar 01; 45(2):212-8. PubMed ID: 3113300
    [Abstract] [Full Text] [Related]

  • 32. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML, Quilliet L, Kulbertus H, Materne P, Letac B, Cribier A, Monassier JP, Sacrez A, Favier JP.
    Drugs; 1987 Mar 01; 33 Suppl 3():140-5. PubMed ID: 3315581
    [Abstract] [Full Text] [Related]

  • 33. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL, Rothbard RL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Dahl CF, Hagan AD, Browne KF, Symkoviak GP, Menlove RL.
    J Am Coll Cardiol; 1988 Jun 01; 11(6):1153-63. PubMed ID: 3284943
    [Abstract] [Full Text] [Related]

  • 34. Pharmacology of fibrinolysis.
    Haire WD.
    Chest; 1992 Apr 01; 101(4 Suppl):91S-97S. PubMed ID: 1555484
    [Abstract] [Full Text] [Related]

  • 35. [T-PA and APSAC, new fibrinolytics].
    Med Monatsschr Pharm; 1986 Nov 01; 9(11):326-7. PubMed ID: 3100917
    [No Abstract] [Full Text] [Related]

  • 36. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov 01; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 37. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP, Hanssen M.
    Drugs; 1987 Nov 01; 33 Suppl 3():247-52. PubMed ID: 2445540
    [Abstract] [Full Text] [Related]

  • 38. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.
    Been M, de Bono DP, Muir AL, Boulton FE, Hillis WS, Hornung R.
    Br Heart J; 1985 Mar 01; 53(3):253-9. PubMed ID: 3882107
    [Abstract] [Full Text] [Related]

  • 39. [Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct].
    Doenecke P, Schwerdt H, Hellstern P, Wenzel E, Bette L.
    Klin Wochenschr; 1986 Aug 01; 64(15):682-7. PubMed ID: 3531704
    [Abstract] [Full Text] [Related]

  • 40. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Munger MA, Forrence EA.
    Clin Pharm; 1990 Jul 01; 9(7):530-40. PubMed ID: 2198125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.